|
Sex (male vs. female)
|
0.72 (0.38–1.38)
|
0.325
|
|
Age (≤ 65 vs. > 65)
|
1.07 (0.63–1.81)
|
0.817
|
|
Diversion type (conduit vs. cutaneous ureterostomy)
|
1.31 (0.80–2.16)
|
0.289
|
|
Diversion type (neobladder vs. cutaneous ureterostomy)
|
0.79 (0.36–1.84)
|
0.476
|
|
Pathological T-stage (MIBC vs. NMIBC)
|
4.96 (2.61–9.40)
|
< 0.001
|
|
Pathological N-stage (N + vs. N−)
|
2.86 (1.31–6.22)
|
0.008
|
|
Smoking history (yes vs. no)
|
0.92 (0.55–1.55)
|
0.756
|
|
Neoadjuvant chemotherapy (yes vs. no)
|
0.92 (0.32–2.61)
|
0.870
|
|
Pentafecta (10 LNs) (yes vs. no)
|
0.31 (0.11–0.89)
|
0.029
|
